Dr. Joshua Brian Eickstaedt, MD

Dr. Eickstaedt practices at Cary Skin Center, PA in Pinehurst, North Carolina.

Dr. Eickstaedt's NPI, 1093961971, was assigned on August 12, 2008. Dr. Eickstaedt graduated from University of Wisconsin School of Medicine in 2008. Dr. Eickstaedt holds North Carolina license 2023-00795.

Dr. Eickstaedt's primary practice is Cary Skin Center, PA, at 5 Regional Cir, Pinehurst, NC 28374 in Moore County. The practice phone is (919) 363-7546.

Dr. Eickstaedt's primary practice is Cary Skin Center, PA in Pinehurst, North Carolina. Dr. Eickstaedt is also affiliated with FirstHealth Moore Regional Hospital. The medical group on file is Cary Skin Center. Dmand AI also links Dr. Eickstaedt to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eickstaedt practices, 3 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Eickstaedt's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Eickstaedt is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Eickstaedt's licenses on file in 3 states: North Carolina, Alabama and Minnesota.

CMS data shows 2,871 Medicare services from Dr. Eickstaedt across 24 procedure codes in 2024, for 697 Medicare patients. Medicare paid $895,413 for them. Every service was in an office.

CMS counts 697 Medicare patients who saw Dr. Eickstaedt in 2024. The largest group is 75 to 84, with 302 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 1.20, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Eickstaedt's median patient age at 76, with 42% women.

In 2024, Dr. Eickstaedt wrote 415 Medicare Part D claims for 330 patients. 97% of them were for generic drugs. CMS names the drug for 353 of them, across 4 drugs with 11 or more claims each, at $1,945 in total drug cost. In 2023, CMS named 949 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Eickstaedt for performance year 2024, reported as part of a group. Dr. Eickstaedt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,033 procedures of removal of skin cancer by Dr. Eickstaedt, more than 87% of the clinicians it reports for that procedure.

CMS Open Payments shows 16 general payments to Dr. Eickstaedt from 8 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 78% of the total. Janssen Pharmaceuticals, Inc paid the most, $297.

Dr. Eickstaedt graduated from University of Wisconsin School of Medicine in 2008.